In this prospective trial of 748 patients presenting with suspected MI, the measurement of three additional biomarkers (BNP, copeptin, and apo A-II), yielded an area under the ROC of 0.82 for the differentiation of Type 1 and Type 2 MI [83]. Here, NPPB is linked to myocardial infarction.